Cargando…
Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development
Systematic genetic interaction profiles can reveal the mechanisms-of-action of bioactive compounds. The imipridone ONC201, which is currently in cancer clinical trials, has been ascribed a variety of different targets. To investigate the genetic dependencies of imipridone action, we screened a genom...
Autores principales: | Jacques, Samuel, van der Sloot, Almer M., C. Huard, Caroline, Coulombe-Huntington, Jasmin, Tsao, Sarah, Tollis, Sylvain, Bertomeu, Thierry, Culp, Elizabeth J., Pallant, Daniel, Cook, Michael A., Bonneil, Eric, Thibault, Pierre, Wright, Gerard D., Tyers, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Genetics Society of America
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153937/ https://www.ncbi.nlm.nih.gov/pubmed/32094149 http://dx.doi.org/10.1534/genetics.119.302851 |
Ejemplares similares
-
Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2
por: Benaroudj, Nadia, et al.
Publicado: (2011) -
A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition
por: Benslimane, Yahya, et al.
Publicado: (2021) -
ClpP Protease, a Promising Antimicrobial Target
por: Moreno-Cinos, Carlos, et al.
Publicado: (2019) -
Effects of ClpP protease on biofilm formation of Enterococcus faecalis
por: FENG, Ying, et al.
Publicado: (2021) -
Cellular functions of the ClpP protease impacting bacterial virulence
por: Aljghami, Mazen E., et al.
Publicado: (2022)